Document:

EX-10.1

 Exhibit 10.1 

AMENDMENT NO. 10 
 This
Amendment No. 10, dated as of April 14, 2014 (this “Amendment”), to that certain Credit Agreement, dated as of August 7, 2007 (as amended by Amendment No. 1, dated as of November 21, 2008, Amendment
No. 2 and Consent, dated as of May 13, 2011, Amendment No. 3, dated as of March 9, 2012, Amendment No. 4, dated as of August 23, 2012, Amendment No. 5, dated as of October 4, 2012, Amendment No. 6, dated
as of February 6, 2013, Amendment No. 7, dated as of February 6, 2013, Amendment No. 8, dated as of August 26, 2013, and Amendment No. 9, dated as of December 31, 2013 (and any Consents related thereto), the
“Credit Agreement”), among ALLISON TRANSMISSION HOLDINGS, INC., a Delaware corporation (“Holdings”), ALLISON TRANSMISSION, INC., a Delaware corporation (the “Borrower”), the several banks and other
financial institutions or entities from time to time parties thereto (the “Lenders”), CITICORP NORTH AMERICA, INC., as Administrative Agent, and the other agents and arrangers parties thereto, is entered into by and among Holdings,
the Borrower, the Agents and the New Term B-2 Lenders (as defined below). Capitalized terms used herein but not defined herein are used as defined in the Credit Agreement. 

WITNESSETH: 

WHEREAS, the Borrower has hereby notified the Administrative Agent and each Term Lender that it intends to incur Specified
Refinancing Debt pursuant to Section 2.26(b) of the Credit Agreement in order to reprice the entire outstanding principal amount of the Term B-2 Loans outstanding under the Credit Agreement immediately prior to the Tenth Amendment Effective
Date (as defined below) (the “Existing Term B-2 Loans”); 
 WHEREAS, pursuant to Section 2.26(c) of the
Credit Agreement, the Borrower may incur Specified Refinancing Debt in order to reprice the Existing Term B-2 Loans by, among other things, entering into this Amendment pursuant to the terms and conditions of the Credit Agreement with Term Lenders
agreeing to provide such Specified Refinancing Debt (each such Term Lender agreeing to provide new Term B-2 Loans (as defined below) and any assignees thereof, are referred to herein as “Term B-2 Lenders); 

WHEREAS, the Borrower has requested that (i) the Lenders executing this Amendment as New Term B-2 Lenders (each, a
“New Term B-2 Lender”) and (ii) the Lenders holding Existing Term B-2 Loans that have executed and delivered a consent to this Amendment substantially in the form of Exhibit A hereto (a “Lender Consent”)
indicating the Rollover Settlement Option (each, a “Rollover Term B-2 Lender”) extend credit to the Borrower in the form of Term Loans in an aggregate principal amount of $423,474,916.11 (the “Term B-2 Loans”; all
of the Term B-2 Loans shall constitute Specified Refinancing Debt referred to herein as the “Term B-2 Facility”); 

WHEREAS, each New Term B-2 Lender has indicated its willingness to lend such Term B-2 Loans up to the aggregate amount
specified on its signature page to this Amendment on the terms and subject to the conditions herein, the proceeds of which will be used by the Borrower to repay the Existing Term B-2 Loans on the Tenth Amendment Effective Date; 

WHEREAS, each Rollover Term B-2 Lender has agreed to make Term B-2 Loans on the Tenth Amendment Effective Date, in an aggregate
amount equal to such Rollover Term B-2 Lender’s Existing Term B-2 Loans (or such lesser amount as may be allocated to such Rollover Term B-2 Lender by the Administrative Agent), the proceeds of which shall be used to repay such Lender’s
Existing Term B-2 Loans, and has authorized the Administrative Agent to execute this Amendment on its behalf; 

 Whereas, each Lender holding an Existing Term B-2 Loan that shall have executed and delivered a
Lender Consent indicating the “Assignment Settlement Option” (each, an “Assignment Term B-2 Lender”) has indicated its willingness to accept an Assignment and Assumption of Term B-2 Loans from Citibank, N.A., as a New Term
B-2 Lender, in an aggregate amount equal to such Assignment Term B-2 Lender’s Existing Term B-2 Loans (or such lesser amount as may be allocated to such Assignment Term B-2 Lender by the Administrative Agent), and has authorized the
Administrative Agent to execute this Amendment on its behalf; 
 NOW, THEREFORE, in consideration of the
premises and agreements, provisions and covenants herein contained, the parties hereto agree as follows: 
 SECTION 1. TERM B-2 FACILITY. 

1.1 Term B-2 Loans. Each Rollover Term B-2 Lender hereby agrees to make Term B-2 Loans up to the aggregate amount of the
aggregate principal amount of such Lender’s Existing Term B-2 Loans on the Tenth Amendment Effective Date. Each New Term B-2 Lender hereby agrees to make Term B-2 Loans up to the aggregate amount specified on such New Term B-2 Lender’s
signature page to this Amendment on the Tenth Amendment Effective Date. Pursuant to Section 2.26 of the Credit Agreement, the Term B-2 Loans shall have the terms set forth in this Amendment and in the Credit Agreement (as amended by this
Amendment). 
 1.2 Applicable Margin; LIBO Rate. The Term B-2 Loans may from time to time be LIBO Rate Loans or Base Rate
Loans, as determined by the Borrower and notified to the Administrative Agent in accordance with Sections 2.13 of the Credit Agreement. In the case of Term B-2 Loans that are LIBO Rate Loans, the Applicable Margin shall mean a percentage per annum
equal to 2.75%. In the case of Term B-2 Loans that are Base Rate Loans, the Applicable Margin shall mean a percentage per annum equal to 1.75%. 

1.3 Use of Proceeds. The proceeds of the Term B-2 Loans shall be applied toward the payment of (a) the aggregate
outstanding principal amount of the Existing Term B-2 Loans and (b) fees, expenses and original issue discount payable in connection with the Term B-2 Loans. 

1.4 Credit Agreement Governs. Effective as of the Tenth Amendment Effective Date, except as set forth in this Amendment,
(a) the Term B-2 Loans shall have identical terms as the Existing Term B-2 Loans (including with respect to maturity, amortization and prepayments) and shall otherwise be subject to the provisions, including any provisions restricting the
rights, or regarding the obligations, of the Loan Parties or any provisions regarding the rights of the Term Lenders, of the Credit Agreement and the other Loan Documents, (b) the Term B-2 Loans shall be Specified Refinancing Debt and Specified
Refinancing Term Loans under the Credit Agreement, (c) this Amendment shall be a Refinancing Amendment under the Credit Agreement, (d) each reference in the Credit Agreement to (i) “Facility” shall be deemed to include the
Term B-2 Facility and (ii) “Majority Facility Lenders”, with respect to the Term B-2 Facility shall be deemed to include the Lenders of more than 50% of the aggregate unpaid principal amount of the Term B-2 Loans outstanding under
such Facility, (e) the definitions of “Term B-2 Facility”, “Term B-2 Lenders”, “Term B-2 Loan Repricing Transaction” and “Term B-2 Loans” in the Credit Agreement are hereby amended and restated in their
entirety to read as follows below and (f) the definition of “Tenth Amendment” and “Tenth Amendment Effective Date” as follows below shall hereby be inserted into Section 1.1 of the Credit Agreement in the correct
alphabetical order: 
 “Term B-2 Facility”: as defined in the Tenth Amendment. 

  
 2 

 “Term B-2 Lenders”: as defined in the Tenth Amendment. 

“Term B-2 Loan Repricing Transaction”: (a) any prepayment or repayment of Term B-2 Loans with the proceeds of, or any
conversion of Term B-2 Loans into, any new or replacement tranche of term loans or Indebtedness incurred for the primary purpose of prepaying, repaying or replacing the Term B-2 Loans and with an All-In Yield for such term loans or Indebtedness less
than the All-In Yield applicable to such Term B-2 Loans and (b) any amendment to the Term B-2 Loans the primary purpose of which is to reduce the All-In Yield applicable to such Term B-2 Loans; provided, that in no event shall any
prepayment, repayment or replacement of Term B-2 Loans in connection with a Change of Control constitute a Term B-2 Loan Repricing Transaction. 

“Term B-2 Loans”: as defined in the Tenth Amendment. 

“Tenth Amendment”: Amendment No. 10 to the Credit Agreement, dated as of April 14, 2014, among Holdings, the
Borrower, the Administrative Agent, the Collateral Agent and the Lenders party thereto. 
 “Tenth Amendment Effective
Date”: as defined in the Tenth Amendment. 
 1.5 Credit Agreement Refinancing Amendments. Effective as of the Tenth
Amendment Effective Date, Section 2.29 of the Credit Agreement shall be amended and restated in its entirety as follows: 

“Section 2.29 Term B-2 Loan Repricing Transaction. Notwithstanding anything to the contrary in this Agreement, in the event that,
on or prior to the six month anniversary of the Tenth Amendment Effective Date, the Borrower (a) makes any prepayment of Term B-2 Loans constituting a Term B-2 Loan Repricing Transaction or (b) effects any amendment of this Agreement
constituting a Term B-2 Loan Repricing Transaction, the Borrower shall pay to the Administrative Agent, for the ratable account of each of the applicable Term B-2 Lenders, (x) in the case of clause (a), a prepayment premium of 1.00% of the
amount of the Term B-2 Loans being prepaid and (y) in the case of clause (b), a payment equal to 1.00% of the aggregate amount of the applicable Term B-2 Loans outstanding immediately prior to such amendment.” 

SECTION 2. CONDITIONS PRECEDENT 

This Amendment shall become effective as of the date (the “Tenth Amendment Effective Date”) on which each of the following
conditions precedent shall have been satisfied or duly waived: 
 2.1 Certain Documents. The Administrative Agent shall have
received each of the following, in form and substance satisfactory to the Administrative Agent: 
 (i) this Amendment, duly
executed by each of the Borrower, Holdings, the Administrative Agent and each New Term B-2 Lender; 
 (ii) Lender Consents
duly executed by each Rollover Term B-2 Lender and each Assignment Term B-2 Lender; 
 (iii) a solvency certificate signed by
the chief financial officer on behalf of the Borrower, substantially in the form of Exhibit G of the Credit Agreement; 

  
 3 

 (iv) a closing certificate of each Loan Party, substantially in the form of
Exhibit B hereto, with appropriate insertions and attachments; and 
 (v) an executed legal opinion of
Latham & Watkins LLP, counsel to the Loan Parties, in form and substance reasonably acceptable to the Administrative Agent. 
 2.2
Fees and Expenses. All fees and reimbursable expenses that have been invoiced as of the Tenth Amendment Effective Date that are due and payable to any Person under any engagement letter entered into in connection with this
Amendment shall have been paid in full in immediately available funds. 
 2.3 Representations and Warranties. Each of the
representations and warranties contained in Section 3 below shall be true and correct. 
 2.4 Minimum Refinancing
Condition. The aggregate principal amount of the Term B-2 Loans shall not be greater, or less, than the aggregate principal amount of the Existing Term B-2 Loans 

2.5 USA Patriot Act. The Term B-2 Lenders shall have received from each of the Loan Parties documentation and other information
required by regulatory authorities under applicable “know your customer” and anti-money laundering rules and regulations, including, without limitation, the USA Patriot Act, to the extent such documentation or other information has been
requested in writing at least five (5) Business Days prior to the Tenth Amendment Effective Date. 
 SECTION 3. REPRESENTATIONS AND WARRANTIES

 Each of Holdings and the Borrower, on behalf of itself and each Loan Party, hereby represents and warrants to the Agents and each
Lender, with respect to all Loan Parties, as follows: 
 3.1 Incorporation of Representations and Warranties from Loan
Documents. After giving effect to this Amendment, each of the representations and warranties in the Credit Agreement and in the other Loan Documents are true and correct in all material respects (except to the extent that such representation
or warranty is qualified as to materiality, in which case it shall be true and correct in all respects) on and as of the date hereof as though made on and as of such date, except to the extent that any such representation or warranty expressly
relates to an earlier date; 
 3.2 Corporate Power and Authority. Each of Holdings and the Borrower has taken all necessary
action to authorize the execution, delivery and performance of this Amendment, this Amendment has been duly executed and delivered by each of Holdings and the Borrower, and this Amendment is the legal, valid and binding obligation of each of
Holdings and the Borrower, enforceable against it in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors’
rights generally and by general equitable principles; and 
 3.3 Absence of Default. Neither Holdings, the Borrower nor any of
its Restricted Subsidiaries is in violation of any Requirement of Law or Contractual Obligation that could reasonably be expected to have a Material Adverse Effect. At the time of and immediately after giving effect to this Amendment, no Default or
Event of Default has occurred and is continuing. 

  
 4 

 SECTION 4. LENDER CONSENTS AND WAIVERS 

4.1 Rollover of Term B-2 Loans. Each Rollover Term B-2 Lender agrees that, upon the Tenth Amendment Effective Date, all (or such
lesser amount as the Administrative Agent may allocate to such Lender) of its Existing Term B-2 Loans shall be converted to Term B-2 Loans under the Credit Agreement, and such Existing Term B-2 Loans shall be deemed repaid in full on the Tenth
Amendment Effective Date, including for all accrued and unpaid interest, fees, expenses and other compensation owed to such Rollover Term B-2 Lender and due and payable by the Borrower pursuant to the Credit Agreement and this Amendment. 

4.2 Assignment of Term B-2 Loans. The Existing Term B-2 Loans of each Lender (other the Loans converted to Term B-2 Loans
pursuant to clause (a) above) shall be repaid in full on the Tenth Amendment Effective Date, including for all accrued and unpaid interest, fees, expenses and other compensation owed to such Lender and due and payable by the Borrower pursuant
to the Credit Agreement and this Amendment. Each Assignment Term B-2 Lender agrees to purchase pursuant to an Assignment and Assumption in accordance with Section 10.06 of the Credit Agreement on or immediately after the Tenth Amendment
Effective Date and assume from a Lender designated by the Administrative Agent Term B-2 Loans in an amount equal to the principal amount of such repayment (or such lesser amount as the Administrative Agent may allocate to such Lender). 

4.3 Waivers. Notwithstanding anything herein to the contrary, each Lender that has executed and delivered a Lender Consent
waives the payment of any breakage loss or expense under Section 2.21 of the Credit Agreement in connection with the repayment of Existing Term B-2 Loans on the Tenth Amendment Effective Date. 

SECTION 5. MISCELLANEOUS 
 5.1
Reference to and Effect on the Loan Documents. 
 (a) As of the Tenth Amendment Effective Date, each reference in the Credit
Agreement to “this Agreement,” “hereunder,” “hereof,” “herein,” or words of like import, and each reference in the other Loan Documents to the Credit Agreement (including, without
limitation, by means of words like “thereunder”, “thereof” and words of like import), shall mean and be a reference to the Credit Agreement as amended by this Amendment. 

(b) Except as expressly amended hereby, all of the terms and provisions of the Credit Agreement and all other Loan Documents are and shall
remain in full force and effect and are hereby ratified and confirmed. 
 (c) The execution, delivery and effectiveness of this Amendment
shall not, except as expressly provided herein, operate as a waiver of any right, power or remedy of the Administrative Agent, any Lender or any Issuing Lender under the Credit Agreement or any Loan Document, or constitute a waiver or amendment of
any other provision of the Credit Agreement or any Loan Document (as amended hereby) except as and to the extent expressly set forth herein. 

5.2 Costs and Expenses. The Borrower agrees to reimburse the Administrative Agent for its costs and expenses in connection with
this Amendment (and the other Loan Documents delivered in connection herewith) as provided in Section 10.5 of the Credit Agreement. 

5.3 Reaffirmation. Each of Holdings and the Borrower hereby confirms that the guaranties, security interests and liens granted
pursuant to the Loan Documents continue to guarantee and secure the 

  
 5 

 
Obligations as set forth in the Loan Documents and that such guaranties, security interests and liens remain in full force and effect. Each of Holdings and the Borrower confirms and ratifies its
obligations under each of the Loan Documents executed by it after giving effect to this Amendment. 
 5.4 Counterparts. This
Amendment may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same
agreement. Receipt by the Administrative Agent of a facsimile copy of an executed signature page hereof shall constitute receipt by the Administrative Agent of an executed counterpart of this Amendment. 

5.5 Governing Law. This Amendment and the rights and obligations of the parties hereto shall be governed by, and construed and
interpreted in accordance with, the law of the State of New York. 
 5.6 Loan Document and Integration. This Amendment is a
Loan Document, and together with the other Loan Documents, incorporates all negotiations of the parties hereto with respect to the subject matter hereof and is the final expression and agreement of the parties hereto with respect to the subject
matter hereof. 
 5.7 Headings. Section headings contained in this Amendment are included herein for convenience of reference
only and shall not constitute a part of this Amendment for any other purposes. 
 5.8 Waiver of Jury Trial. EACH OF THE
PARTIES HERETO IRREVOCABLY WAIVES TRIAL BY JURY IN ANY ACTION OR PROCEEDING WITH RESPECT TO THIS AMENDMENT OR ANY OTHER LOAN DOCUMENT. 

[SIGNATURE PAGES FOLLOW] 

  
 6 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed by their
respective officers and members thereunto duly authorized, as of the date indicated above. 
  

			
	ALLISON TRANSMISSION HOLDINGS, INC.
		
	By:	 	 /s/ David S. Graziosi

	Name:	 	David S. Graziosi
	Title:	 	Executive Vice President, Chief Financial Officer and Treasurer
	
	ALLISON TRANSMISSION, INC.
		
	By:	 	 /s/ David S. Graziosi

	Name:	 	David S. Graziosi
	Title:	 	Executive Vice President, Chief Financial Officer and Treasurer

 [SIGNATURE PAGE TO AMENDMENT NO. 10] 

 
			
	 CITICORP NORTH AMERICA, INC., as Administrative Agent and Collateral Agent

		
	By:	 	 /s/ Matthe Burke

	Name:	 	Matthe Burke
	Title:	 	Vice President

 Name of Lender: CITIBANK, N.A. 
  

					
	Executing as a New Term B-2 Lender:
			
		 	by	 	 /s/ Matthe Burke

		 	Name:	 	Matthe Burke
		 	Title:	 	Vice President
	
	For any Institution requiring a second signature line:
			
		 	by	 	  

		 	Name:	 	
		 	Title:	 	

  

					
	 Credit Agreement Reference
	  	Aggregate Principal Amount	 
	 Term B-2 Loan
	  	$	89,542,910.86	  

 Exhibit A 

Lender Consent to Amendment No. 10 
 This Lender
Consent (“Lender Consent”) to Amendment No. 10 (the “Amendment”) to that certain Credit Agreement, dated as of August 7, 2007 (as amended by Amendment No. 1, dated as of November 21, 2008,
Amendment No. 2 and Consent, dated as of May 13, 2011, Amendment No. 3, dated as of March 9, 2012, Amendment No. 4, dated as of August 23, 2012, Amendment No. 5, dated as of October 4, 2012, Amendment
No. 6, dated as of February 6, 2013, Amendment No. 7, dated as of February 6, 2013, Amendment No. 8, dated as of August 26, 2013, and Amendment No.9, dated as of December 31, 2013 (and any Consents related
thereto), the “Credit Agreement”), among Allison Transmission Holdings, Inc., a Delaware corporation, Allison Transmission, Inc., a Delaware corporation (the “Borrower”), the several banks and other financial
institutions or entities from time to time parties thereto, Citicorp North America, Inc., as Administrative Agent, and the other agents and arrangers parties thereto. Capitalized terms used but not defined in this Lender Consent have the meanings
assigned to such terms in the Credit Agreement (as amended by the Amendment). 
 The undersigned hereby irrevocably and unconditionally agrees to the
following (check only ONE option): 
 Rollover Settlement Option 
  

	 ̈	to deem prepaid 100% of the outstanding principal amount of the Existing Term B-2 Loans held by such Lender (or such lesser amount allocated to such Lender by the Administrative Agent) with proceeds of a new Term B-2
Loan in a like principal amount. 

 Assignment Settlement Option 

 

	 ̈	to have 100% of the outstanding principal amount of the Existing Term B-2 Loans held by such Lender prepaid on the Tenth Amendment Effective Date and to purchase by assignment new Term B-2 Loans in a like principal
amount (or such lesser amount allocated to such Lender by the Administrative Agent). 

 IN WITNESS WHEREOF, the undersigned has caused this
Lender Consent to be executed and delivered by a duly authorized signatory as of the      of April, 2014. 
  

			
	  

	 (insert name of the legal entity above)

as a Term B-2 Lender

		
	by	 	  

	Name:	 	
	Title:	 	
	
	For any Institution requiring a second signature line:
		
	by	 	  

	Name:	 	
	Title:	 	

  

			
	Name of Fund Manager (if applicable):	 	
                     
                            

 Exhibit B 

FORM OF CLOSING CERTIFICATE 

CLOSING CERTIFICATE 
 OF

 ALLISON TRANSMISSION HOLDINGS, INC. 

Pursuant to Section 2.1(d) of Amendment No. 10, dated as of April,     , 2014 (the “Amendment”;
unless otherwise defined herein, terms defined in the Amendment and used herein shall have the meanings given to them in the Amendment), to that certain Credit Agreement, dated as of August 7, 2007 (as amended, restated, supplemented or
otherwise modified from time to time, including but not limited to, the Amendment, the “Credit Agreement”), among Allison Transmission Holdings, Inc. (“Holdings”), Allison Transmission, Inc. (the
“Borrower”), the several banks and other financial institutions or entities from time to time parties to the Credit Agreement as lenders (the “Lenders”), Citicorp North America, Inc., as Administrative Agent, and
the other agents and arrangers parties thereto, the undersigned Assistant Secretary of Allison Transmission Holdings, Inc. (the “Company”), hereby certifies on behalf of the Company as follows: 

 

	 	1.	Eric C. Scroggins is the duly elected and qualified Secretary of the Company and the signature set forth for such officer below is such officer’s true and genuine signature. 

The undersigned Secretary of the Company hereby certifies as follows: 

 

	 	1.	Attached hereto as Annex 1 is a true and complete copy of a Certificate of Good Standing or the equivalent from the Company’s jurisdiction of organization dated as of a recent date prior to the date hereof.

  

	 	2.	Attached hereto as Annex 2 is a true and complete copy of resolutions duly adopted by the Board of Directors of the Company on
[                    ]. Such resolutions have not in any way been amended, modified, revoked or rescinded, have been in full force and effect since
their adoption to and including the date hereof and are now in full force and effect and are the only corporate proceedings of the Company now in force relating to or affecting the matters referred to therein. 

 

	 	3.	Attached hereto as Annex 3 is a true and complete copy of the Bylaws of the Company as in effect on the date hereof. 

  

	 	4.	Attached hereto as Annex 4 is a true and complete certified copy of the Articles of Incorporation of the Company as in effect on the date hereof, and such Articles of Incorporation have not been amended,
repealed, modified or restated. 

  

	 	5.	The persons listed on Schedule I hereto are now duly elected and qualified officers of the Company holding the offices indicated next to their respective names on Schedule I hereto, and the signatures appearing opposite
their respective names on Schedule I hereto are the true and genuine signatures of such officers, and each of such officers is duly authorized to execute and deliver on behalf of the Company each of the Loan Documents to which it is a party and any
certificate or other document to be delivered by the Company pursuant to the Loan Documents to which it is a party. 

  

	 	6.	Latham & Watkins LLP may rely on this certificate in rendering its opinion. 

 IN WITNESS WHEREOF, the undersigned have hereunto set our names as of the date set forth below.

  

									
		 		 		 	ALLISON TRANSMISSION HOLDINGS, INC.
			
	  
	 		 	  

	Name:	 	Eric C. Scroggins	 		 	Name:	 	David S. Graziosi
	Title:	 	Vice President, General Counsel and Secretary	 		 	Title:	 	Executive Vice President, Chief Financial Officer, Treasurer and Assistant Secretary

 Date: [            ], 2014 

 Schedule I 

to Closing Certificate 
  

							
	 NAME
	 	 OFFICE
	 	 	 	 SIGNATURE

				
	 David S. Graziosi
	 	Executive Vice President, Chief Financial Officer, Treasurer and Assistant Secretary	 		 	  

				
	 Eric C. Scroggins
	 	Vice President, General Counsel and SecretaryEX-10.2

 Exhibit 10.2 
 Employment Agreement 
 This Employment Agreement (the
“Agreement”) dated as of April 15, 2014, is made by and between Allison Transmission, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Lawrence E. Dewey (the
“Executive”) (collectively referred to as the “Parties”). 
 RECITALS 

 

	A.	It is the desire of the Company to assure itself of the services of the Executive by entering into this Agreement. 

 

	B.	The Executive and the Company mutually desire that the Executive provide services to the Company on the terms herein provided. 

AGREEMENT 

NOW, THEREFORE, in consideration of the foregoing and of the respective covenants and agreements set forth below the Parties hereto agree
as follows: 
  

	1.	Employment. 

  

	 	(a)	General. The Company shall employ the Executive and the Executive shall enter the employ of the Company, for the period set forth in Section 1(b), in
the position set forth in Section 1(c), and upon the other terms and conditions herein provided. 

  

	 	(b)	Employment Term. The initial term of employment under this Agreement (the “Initial Term”) shall be for the period beginning on the Effective
Date and ending on February 28, 2017, unless earlier terminated as provided in Section 3. On February 28, 2017 and each successive anniversary, the employment term hereunder shall automatically be extended for an additional
one-year period (“Extension Terms” and, collectively with the Initial Term, the “Term”) unless either Party gives notice of non-extension to the other no later than ninety (90) days prior to the then-applicable anniversary
of the Effective Date (in which case the Executive’s employment will terminate at the end of the then-applicable Term or any other date set by the Company in accordance with Section 3(b)) and subject to earlier termination as provided in
Section 3. 

  

	 	(c)	 Position and Duties. The Executive shall serve as the Chairman of the Board, President, and Chief Executive Officer of the Company and Allison
Transmission Holdings, Inc. (“Parent”) with such customary responsibilities, duties and authority as may from time to time be assigned to the Executive by the Board of Directors of the Company, the Board of Directors of Parent or an
authorized committee of either board (collectively, the “Board”). The Executive shall report to the Board. The Executive shall devote substantially all his working time and efforts to the business and affairs of the Company

	 	
(which shall include service to its affiliates, if applicable). The Executive agrees to observe and comply with the rules and policies of the Company as adopted by the Company from time to time.
During the Term, it shall not be a violation of this Agreement for the Executive to (i) serve on industry trade, civic or charitable boards or committees; (ii) deliver lectures or fulfill speaking engagements; (iii) manage his
personal investments and affairs; and (iv) serve on the board of directors of two for-profit enterprises with the Board’s prior consent, as long as such activities do not interfere with the performance of the Executive’s duties and
responsibilities as an employee of the Company. 

  

	2.	Compensation and Related Matters. 

  

	 	(a)	Annual Base Salary. During the Term, the Executive shall receive a base salary at a rate of $ 800,000 per annum (the “Annual Base Salary”),
which shall be paid in accordance with the customary payroll practices of the Company. The Annual Base Salary shall be reviewed (and may be adjusted upward) at least annually by the Board. 

 

	 	(b)	Bonus. During the Term, the Executive shall be eligible to receive an annual performance-based bonus upon the achievement of certain performance goals, which
performance goals shall be determined by the Board in good faith after consultation with the Executive. (the “Performance Bonus”). The Performance Bonus shall have a target equal to 150% of the Annual Base Salary (the
“Target Bonus”) and the Executive shall have the ability to earn more (up to 375% of Annual Base Salary) or less than the Target Bonus depending on the achievement of performance goals for the particular year, as follows:

  

	 	(i)	Over Performance: The amount of formulaic Performance Bonus earned by the Executive shall be increased by 6% of the Target Bonus for each percentage of
performance that exceeds the target performance goals for the year in question (rounded to the nearest percentage); provided, that the Performance Bonus earned in any one year shall not exceed 375% of Annual Base Salary. For example, if the
formulaic performance is 110% of target, the Executive’s formulaic payout is calculated at 240% of base salary (i.e., 150% of base salary for Target, plus 90% of base salary (6% x 150% x 10) = a bonus total of 240% of base salary).

  

	 	(ii)	Threshold Performance: The amount of formulaic Performance Bonus earned by the Executive shall be decreased by 5% of the Target Bonus for every percentage of
performance that is less than the target performance goals for the year in question. For example, if the formulaic performance is 85% of target, the Executive’s formulaic payout is calculated at 37.5% of base salary (i.e., 150% of base salary
for Target, less 5% x 150% x 15 = a net bonus total of 37.5% of base salary). 

  
 2 

	 	(iii)	The Performance Bonus for a particular year shall become due and payable only if the Executive remains employed with the Company as of the January 1 following such
year (the “Service Trigger Date”). If a Performance Bonus becomes due and payable for a particular year, then the Company shall pay such Performance Bonus to the Executive on the same day that the Company pays similar bonuses to
other executives of the Company, provided, however, that the Company shall in no event pay the Performance Bonus to the Executive after March 15 of the year following the year in which the applicable Service Trigger Date
occurs. Notwithstanding anything to the contrary in this Section 2(b), the Board may make reasonable adjustments, up or down, to the amount of Performance Bonus payable for any year to take into account extraordinary events, such as
acquisitions, dispositions and unusual or one time earnings fluctuations. 

  

	 	(c)	Long Term Incentive (LTI) Program. During the Term, the Executive will be eligible to receive long term incentive compensation in the form of equity compensation
or cash, as determined by the Board, consistent with the LTI Program provided to senior officers of the Company. Consistent with the target dollar value for the 2013-2015 LTI Program, the Executive’s target value for the 2014-2016 LTI Program
will be set at $3,000,000 (the “LTI Target”). Such LTI Program incentives will be established at the beginning of each three year period (i.e. 2015-2017, and 2016-2018) and may be adjusted by the Board, but in no case will it be
established at a target level below $3,000,000 during the Initial Term, with a minimum of 30% of the target level value comprised of restricted stock units or restricted stock. 

 

	 	(d)	Retention and Incentive Awards. During the Term, the Executive will receive the following cash retention and incentive awards (the “Retention
Bonuses”): 

  

	 	(i)	2014: $150,000, payable in the January 15, 2015 salaried payroll processing; 

 

	 	(ii)	2015: $300,000, payable in the January 15, 2016 salaried payroll processing; 

 

	 	(iii)	2016: $500,000, payable in the January 15, 2017 salaried payroll processing. 

 

	 	(e)	Restricted Stock Award. Separate from any LTI Program, as soon as reasonably practicable following the Effective Date, the Executive will receive 60,000 shares
of restricted common stock of Parent with the following vesting schedule: 

  

	 	(i)	20,000 shares vesting on January 31, 2015; 

  
 3 

	 	(ii)	20,000 shares vesting on January 31, 2016; and 

  

	 	(iii)	20,000 shares vesting on January 31, 2017. 

  

	 	(f)	Benefits. During the Term, the Executive shall be eligible to participate in employee benefit plans, programs and arrangements of the Company, as may be amended
from time to time, which are generally applicable to senior officers of the Company and its subsidiaries, which as of the time of this Agreement include the Company’s health and welfare plan and the Equity Incentive Plan of Parent (pursuant to
the terms to be set forth in a separate award agreement). If the group life insurance program of the Company does not permit coverage for the Executive as a multiple of annual salary comparable to that afforded other salaried and/or executive
employees (currently 10 times annual salary), the Company will reimburse the Executive for the cost of an additional term life policy for the difference, up to a maximum of $15,000 annually. 

 

	 	(g)	Vacation. During the Term, the Executive shall be entitled to paid vacation in accordance with the Company’s vacation policy, as it may be amended from time
to time; provided, however, the Executive shall be entitled to no less than twenty eight days of paid vacation each calendar year. Any vacation shall be taken at the reasonable and mutual convenience of the Company and the Executive.

  

	 	(h)	Expenses. During the Term, the Company shall reimburse the Executive for all reasonable travel and other business expenses incurred by him in the performance of
his duties to the Company in accordance with the Company’s expense reimbursement policy. 

  

	 	(i)	Key Person Insurance. At any time during the Term, the Company shall have the right to insure the life of the Executive for the Company’s sole benefit. The
Company shall have the right to determine the amount of insurance and the type of policy. The Executive shall reasonably cooperate with the Company in obtaining such insurance by submitting to physical examinations, by supplying all information
reasonably required by any insurance carrier, and by executing all necessary documents reasonably required by any insurance carrier. The Executive shall incur no financial obligation by executing any required document, and shall have no interest in
any such policy. 

  

	3.	Termination. 

 The
Executive’s employment hereunder may be terminated by the Company or the Executive, as applicable, without any breach of this Agreement only under the following circumstances: 

 

	 	(a)	Circumstances. 

  

	 	(i)	Death. The Executive’s employment hereunder shall terminate upon his death. 

  
 4 

	 	(ii)	Disability. If the Executive has incurred a Disability, as defined in Section 10(e), the Company may terminate the Executive’s employment.

  

	 	(iii)	Termination for Cause. The Company may terminate the Executive’s employment for Cause, as defined in Section 10(b). 

 

	 	(iv)	Termination without Cause. The Company may terminate the Executive’s employment without Cause. 

 

	 	(v)	Resignation for Good Reason. The Executive may resign his employment for Good Reason, as defined in Section 10(f). 

 

	 	(vi)	Resignation without Good Reason. The Executive may resign his employment without Good Reason. 

 

	 	(vii)	Non-extension of Term by the Company. The Company may give notice of non-extension to the Executive pursuant to Section 1(b). 

  

	 	(viii)	Non-extension of Term by the Executive. The Executive may give notice of non-extension to the Company pursuant to Section 1(b) and the last day of
the applicable Term shall be the Executive’s Date of Termination and shall be considered the Executive’s “Retirement” hereunder. 

 

	 	(b)	Notice of Termination. Any termination of the Executive’s employment by the Company or by the Executive under this Section 3 (other than
termination pursuant to paragraph (a)(i)) shall be communicated by a written notice to the other Party hereto indicating the specific termination provision in this Agreement relied upon, setting forth in reasonable detail the facts and circumstances
claimed to provide a basis for termination of the Executive’s employment under the provision so indicated, and specifying a Date of Termination, as defined in Section 10(d), which shall be at least 60 days following the date of such notice
in the event of any termination of the Executive’s employment other than a Termination for Cause and at least 45 days following the date of such notice in the event of a Termination for Cause (a “Notice of Termination”). The
failure by the Company to set forth in the Notice of Termination any fact or circumstance which contributes to a showing of Cause shall not waive any right of the Company hereunder or preclude the Company from asserting such fact or circumstance in
enforcing the Company’s rights hereunder. Similarly, the failure by Executive to set forth in the Notice of Termination any fact or circumstance which contributes to a showing of Good Reason shall not waive any right of the Executive hereunder
or preclude the Executive from asserting such fact or circumstance in enforcing Executive’s rights hereunder. 

  
 5 

	 	(c)	Company Obligations upon Termination. Upon termination of the Executive’s employment pursuant to any of the circumstances listed in
Section 3(a), the Executive (or the Executive’s estate) shall be entitled to receive the sum of: (i) the portion of the Executive’s Annual Base Salary earned through the Date of Termination, but not yet paid to the
Executive; (ii) any bonus actually earned by the Executive in the year prior to the year in which the Date of Termination occurs, but not yet paid to the Executive; (iii) any expenses owed to the Executive under Section 2(h);
(iv) any accrued vacation pay owed to the Executive pursuant to Section 2(g), and (v) any amount accrued and arising from the Executive’s participation in, or benefits accrued under any employee benefit plans, programs or
arrangements under Section 2(f) (including, but not limited to, deferred compensation plans and vested company matching funds), which amounts shall be payable in accordance with the terms and conditions of such employee benefit plans,
programs or arrangements. (collectively, the “Company Arrangements”). For the avoidance of doubt, upon termination of the Executive’s employment for any reason, the Executive shall not be entitled to any other payments or
benefits (including Annual Base Salary) except as specifically provided for in this Section 3(c) or Section 4. 

  

	4.	Severance Payments. 

  

	 	(a)	Termination for Cause, or Resignation without Good Reason. If the Executive’s employment shall terminate pursuant to Section 3(a)(iii) for
Cause, or the Executive Resigns without Good Reason, the Executive shall not be entitled to any severance payment or benefits. 

  

	 	(b)	Termination upon Retirement. If the Executive’s employment shall terminate pursuant to Section 3(a)(viii) due to Executive’s Retirement
then, subject to the Executive signing, within forty-five (45) days following delivery to the Executive, which such delivery occurring within five (5) days from the Date of Termination, a release of claims against the Company in
substantially the form attached hereto as Exhibit A (the “Release”), and the Executive’s continued compliance with Sections 5 and 6, the Executive shall receive: 

 

	 	(i)	Pro-rated Vesting; and 

  

	 	(ii)	Continued Healthcare Coverage for twenty (24) months. 

  

	 	(c)	Death or Disability. If the Executive’s employment shall terminate as a result of Executive’s Death pursuant to Section 3(a)(i), or Disability
pursuant to Section 3(a)(ii) then, subject to the Executive (or his designated representative) signing, within forty-five (45) days following delivery to the Executive, which such delivery occurring within five (5) days from the Date
of Termination, the Release, and not revoking such Release, within the revocation period specified in the Release, and the Executive’s continued compliance with Sections 5 and 6, the Executive shall receive: 

 

	 	(i)	A lump sum payment equal to 2.0 times the Executive’s Annual Base Salary as of the Date of Termination, payable within sixty (60) days following the Date of
Termination; 

  
 6 

	 	(ii)	A lump sum payment equal to 2.0 times the Average Annual Bonus, payable within sixty (60) days following the Date of Termination; 

 

	 	(iii)	Pro-rata Vesting; and 

  

	 	(iv)	Continued Healthcare Coverage until the Executive (or surviving spouse) reaches the age of sixty five (65). 

 

	 	(d)	Termination without Cause, Resignation for Good Reason or upon Non-extension of Term by the Company. If the Executive’s employment shall terminate without
Cause pursuant to Section 3(a)(iv), shall terminate due to the Executive’s resignation for Good Reason pursuant to Section 3(a)(v) or pursuant to Section 3(a)(vii) due to Non-extension of the Term by the
Company then, subject to the Executive signing, within forty-five (45) days following delivery to the Executive, which such delivery occurring within five (5) days from the Date of Termination, the Release, and not revoking such Release,
within the revocation period specified in the Release, and the Executive’s continued compliance with Sections 5 and 6, the Executive shall receive: 

 

	 	(i)	A lump sum payment equal to 3.0 times the Annual Base Salary as of the Date of Termination, payable within sixty (60) days following the Date of Termination;

  

	 	(ii)	A lump sum payment equal to 3.0 times the Average Annual Bonus, payable within sixty (60) days following the Date of Termination; 

 

	 	(iii)	Full and immediate vesting of all unvested LTI Program awards granted to the Executive by the Company; provided, however, that any performance-based LTI Program awards
shall only vest and become payable subject to the attainment of the performance measures for the applicable performance period as provided under the terms of the applicable award agreement, which performance-based amount will vest and be paid to
Executive at the time originally scheduled to be paid to Executive under the terms of the applicable award agreement; 

  

	 	(iv)	A lump sum payment of the unpaid Retention and Incentive Awards, payable within sixty (60) days following the Date of Termination; and 

 

	 	(v)	Continued Healthcare Coverage for thirty six (36) months following the Date of Termination. 

If the payment of any amounts under Section 4 are delayed pending the Executive’s execution of the Release, as soon as
reasonably practicable following 

  
 7 

 
the date the Release becomes effective (but in no event later than, subject to Section 23, the earlier of (i) 30 days after the Release becomes effective, and
(ii) March 15th of the calendar year following
the calendar year in which the Release becomes effective), the Company will pay the Executive the amounts that would have otherwise been previously paid to the Executive under Section 4 prior to the execution of such Release, provided
that he has not revoked such Release. For the avoidance of doubt, no payments or benefits under Section 4 shall be made until the Executive has executed the Release and the required revocation period specified in the Release has expired;
provided, however, to the extent Pro-rata Vesting relates to restricted stock that is not subject to performance based vesting, then the Pro-rata Vesting with respect to such restricted stock shall occur without regard to the Release requirement.

  

	 	(e)	Survival. The expiration or termination of the Term shall not impair the rights or obligations of any Party hereto, which shall have accrued prior to such
expiration or termination 

  

	 	(f)	No Mitigation. Executive shall not be required to mitigate the amount of any payment provided for in this Section 4 by seeking other employment or
otherwise, nor shall the amount of any payment or benefit provided for in this Section 4 to be reduced by any compensation earned by the Executive as the result of employment by another employer, self-employment or by retirement benefits;
provided, however, that loans, advances or other amounts owed by the Executive to the Company may be offset by the Company against cash amounts payable to the Executive under this Section 4 at the time such cash amounts are payable to
the Executive under this Section 4. 

  

	 	(g)	Return of the Company’s Property. If the Executive’s employment is terminated for any reason, the Company shall have the right, at its option, to
require the Executive to vacate his offices prior to or on the effective date of termination and to cease all activities on the Company’s behalf. Upon the termination of his or her employment in any manner, as a condition to the
Executive’s receipt of any post-termination benefits described in this Agreement, the Executive shall immediately surrender to the Company all lists, books and records of, or in connection with, the Company’s business, and all other
property belonging to the Company, it being distinctly understood that all such lists, books and records, and other documents are the property of the Company. 

 

	 	(h)	Parachute Payments. 

  

	 	(i)	 It is the objective of this Agreement to maximize Executive’s Net After-Tax Benefit (as defined herein) if payments or benefits provided under
this Agreement are subject to excise tax under Section 4999 of the Code. Notwithstanding any other provisions of this Agreement, in the event that any payment or benefit by the Company or otherwise to or for the benefit of Executive, whether
paid or payable or distributed 

  
 8 

	 	
or distributable pursuant to the terms of this Agreement or otherwise (all such payments and benefits, including the payments and benefits under Section 4 hereof, being hereinafter referred
to as the “Total Payments”), would be subject (in whole or in part) to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then the cash severance payments shall first be reduced, and the
non-cash severance payments shall thereafter be reduced, to the extent necessary so that no portion of the Total Payments shall be subject to the Excise Tax, but only if (i) the net amount of such Total Payments, as so reduced (and after
subtracting the net amount of federal, state and local income taxes on such reduced Total Payments and after taking into account the phase out of itemized deductions and personal exemptions attributable to such reduced Total Payments), is greater
than or equal to (ii) the net amount of such Total Payments without such reduction (but after subtracting the net amount of federal, state and local income taxes on such Total Payments and the amount of Excise Tax to which Executive would be
subject in respect of such unreduced Total Payments and after taking into account the phase out of itemized deductions and personal exemptions attributable to such unreduced Total Payments). 

 

	 	(ii)	The Total Payments shall be reduced by the Company in the following order: (i) reduction of any cash severance payments otherwise payable to Executive that are
exempt from Section 409A of the Code, (ii) reduction of any other cash payments or benefits otherwise payable to Executive that are exempt from Section 409A of the Code, but excluding any payments attributable to the acceleration of
vesting or payments with respect to any equity award with respect to the Parent’s common stock that is exempt from Section 409A of the Code, (iii) reduction of any other payments or benefits otherwise payable to Executive on a
pro-rata basis or such other manner that complies with Section 409A of the Code, but excluding any payments attributable to the acceleration of vesting and payments with respect to any equity award with respect to the Parent’s common stock
that are exempt from Section 409A of the Code, and (iv) reduction of any payments attributable to the acceleration of vesting or payments with respect to any other equity award with respect to the Parent’s common stock that are exempt
from Section 409A of the Code. 

  

	 	(iii)	 All determinations regarding the application of this Section 4(h) shall be made by an accounting firm with experience in performing calculations
regarding the applicability of Section 280G of the Code and the Excise Tax selected by the Company (“Independent Advisors”). For purposes of determining whether and the extent to which the Total Payments will be subject to the
Excise Tax, (i) no portion of the Total Payments the receipt or enjoyment of which Executive shall have waived at such time and in such manner as not to constitute a “payment” within the meaning of Section 280G(b) of the Code
shall be 

  
 9 

	 	
taken into account, (ii) no portion of the Total Payments shall be taken into account which, in the opinion of the Independent Advisors, does not constitute a “parachute payment”
within the meaning of Section 280G(b)(2) of the Code (including by reason of Section 280G(b)(4)(A) of the Code) and, in calculating the Excise Tax, no portion of such Total Payments shall be taken into account which, in the opinion of
Independent Advisors, constitutes reasonable compensation for services actually rendered, within the meaning of Section 280G(b)(4)(B) of the Code, in excess of the “base amount” (as defined in Section 280G(b)(3) of the Code)
allocable to such reasonable compensation, and (iii) the value of any non-cash benefit or any deferred payment or benefit included in the Total Payments shall be determined by the Independent Advisors in accordance with the principles of
Sections 280G(d)(3) and (4) of the Code. The costs of obtaining such determination and all related fees and expenses (including related fees and expenses incurred in any later audit) shall be borne by the Company. 

 

	 	(iv)	In the event it is later determined that a greater reduction in the Total Payments should have been made to implement the objective and intent of this
Section 4(h), the excess amount shall be returned immediately by the Executive to the Company, plus interest at a rate equal to 120% of the semi-annual applicable federal rate as in effect at the time of the Change in Control.

  

	5.	Competition. 

  

	 	(a)	The Executive shall not, at any time during the Term and for twenty four months after the Date of Termination, directly or indirectly engage in, have any equity
interest in, interview for a potential employment or consulting relationship with or manage or operate any person, firm, corporation, partnership or business (whether as director, officer, employee, agent, representative, partner, security holder,
consultant or otherwise) that engages in any business which competes with any portion of the Business (as defined below) of the Company anywhere in the world. Notwithstanding the foregoing, it shall not be a violation of this Section 5(a) for
the Executive to join a division or business line of a commercial enterprise, other than any Specified Entity, with multiple divisions or business lines if such division or business line is not competitive with the businesses of the Company and its
subsidiaries, provided that the Executive performs services solely for such non-competitive division or business line, and performs no functions on behalf of (and has no involvement with or direct or indirect responsibilities with respect to)
businesses competitive with the Business of the Company anywhere in the world. Nothing herein shall prohibit the Executive from being a passive owner of not more than 4.9% of the outstanding equity interest in any entity, other than any Specified
Entity, which is publicly traded, so long as the Executive has no active participation in the business of such entity. 

  
 10 

	 	(b)	The Executive shall not, at any time during the Term and for eighteen months after the Date of Termination, directly or indirectly, recruit or otherwise solicit or
induce any employee, customer, subscriber or supplier of the Company (i) to terminate its employment or arrangement with the Company, or (ii) to otherwise change its relationship with the Company. 

 

	 	(c)	In the event the terms of this Section 5 shall be determined by any court of competent jurisdiction to be unenforceable by reason of its extending for too
great a period of time or over too great a geographical area or by reason of its being too extensive in any other respect, it will be interpreted to extend only over the maximum period of time for which it may be enforceable, over the maximum
geographical area as to which it may be enforceable, or to the maximum extent in all other respects as to which it may be enforceable, all as determined by such court in such action. 

 

	 	(d)	As used in this Section 5, (i) the term “Company” shall include the Company, its subsidiaries, and Allison Transmission Holdings,
Inc., the parent of the Company, and (ii) the term “Business” shall include the manufacturing, development and sale of transmissions and the sale of replacement parts, “will-fit” parts, support equipment and
remanufactured transmissions for use in the vehicle aftermarket, as such business may be expanded or altered by the Company during the Term. 

  

	 	(e)	The Executive agrees, during the Term and following the Date of Termination, to refrain from disparaging the Company and its affiliates, including any of its services,
technologies or practices, or any of its directors, officers, agents, representatives or stockholders, either orally or in writing. The Company agrees, during the Term and following the Date of Termination, to refrain from disparaging the Executive;
provided, however, that the Company’s agreement to this non-disparagement clause shall be limited to official statements issued by the Company as an organization and statements of officers of the Company and members of the Board in their
official capacity as representatives of the Company. Nothing in this paragraph shall preclude the Executive, the Company, the members of the Board or officers of the Company from making truthful statements that are reasonably necessary to comply
with applicable law, regulation or legal process. 

  

	6.	Nondisclosure of Proprietary Information. 

  

	 	(a)	 Except in connection with the faithful performance of the Executive’s duties hereunder or pursuant to Section 6(c) and (e), the
Executive shall, in perpetuity, maintain in confidence and shall not directly, indirectly or otherwise, use, disseminate, disclose or publish, or use for his benefit or the benefit of any person, firm, corporation or other entity any confidential or
proprietary information or trade secrets of or relating to the Company (including, without limitation, business plans, business strategies and methods, acquisition targets, intellectual property in the form of patents,

  
 11 

	 	
trademarks and copyrights and applications therefor, ideas, inventions, works, discoveries, improvements, information, documents, formulae, practices, processes, methods, developments, source
code, modifications, technology, techniques, data, programs, other know-how or materials, owned, developed or possessed by the Company, whether in tangible or intangible form, information with respect to the Company’s operations, processes,
products, inventions, business practices, finances, principals, vendors, suppliers, customers, potential customers, marketing methods, costs, prices, contractual relationships, regulatory status, prospects and compensation paid to employees or other
terms of employment) (collectively, the “Confidential Information”), or deliver to any person, firm, corporation or other entity any document, record, notebook, computer program or similar repository of or containing any such
Confidential Information. The Parties hereby stipulate and agree that, as between them, any item of Confidential Information is important, material and confidential and affects the successful conduct of the businesses of the Company (and any
successor or assignee of the Company). Notwithstanding the foregoing, Confidential Information shall not include any information that has been published in a form generally available to the public prior to the date the Executive proposes to disclose
or use such information, provided, that such publishing of the Confidential Information shall not have resulted from the Executive directly or indirectly breaching his obligations under this Section 6(a) or any other similar provision by
which he is bound, or from any third-party breaching a provision similar to that found under this Section 6(a). For the purposes of the previous sentence, Confidential Information will not be deemed to have been published or otherwise disclosed
merely because individual portions of the information have been separately published, but only if all material features comprising such information have been published in combination. 

 

	 	(b)	Upon termination of the Executive’s employment with the Company for any reason, the Executive will promptly deliver to the Company all correspondence, drawings,
manuals, letters, notes, notebooks, reports, programs, plans, proposals, financial documents, or any other documents or property concerning the Company’s customers, business plans, marketing strategies, products, property or processes.

  

	 	(c)	The Executive may respond to a lawful and valid subpoena or other legal process but shall give the Company the earliest possible notice thereof, shall, as much in
advance of the return date as possible, make available to the Company and its counsel the documents and other information sought and shall assist such counsel at Company’s expense in resisting or otherwise responding to such process.

  

	 	(d)	As used in this Section 6 and Section 7, the term “Company” shall include the Company, its subsidiaries, and Allison
Transmission Holdings, Inc., the parent of the Company. 

  
 12 

	 	(e)	Nothing in this Agreement shall prohibit the Executive from (i) disclosing information and documents when required by law, subpoena or court order (subject to the
requirements of Section 6(c) above), (ii) disclosing information and documents to his attorney or tax adviser for the purpose of securing legal or tax advice, (iii) disclosing the Executive’s post-employment restrictions
in this Agreement in confidence to any potential new employer, or (iv) retaining, at any time, his personal correspondence, his personal contacts and documents related to his own personal benefits, entitlements and obligations.

  

	7.	Inventions.  

 All
rights to discoveries, inventions, improvements and innovations (including all data and records pertaining thereto) related to the business of the Company, whether or not patentable, copyrightable, registrable as a trademark, or reduced to writing,
that the Executive may discover, invent or originate during the Term, either alone or with others and whether or not during working hours or by the use of the facilities of the Company (“Inventions”), shall be the exclusive property
of the Company. The Executive shall promptly disclose all Inventions to the Company, shall execute at the request of the Company any assignments or other documents the Company may deem reasonably necessary to protect or perfect its rights therein,
and shall assist the Company, upon reasonable request and at the Company’s expense, in obtaining, defending and enforcing the Company’s rights therein. The Executive hereby appoints the Company as his
attorney-in-fact to execute on his behalf any assignments or other documents reasonably deemed necessary by the Company to protect or perfect its rights to any Inventions. 

 

	8.	Injunctive Relief. 

It is recognized and acknowledged by the Executive that a breach of the covenants contained in Sections 5, 6 and 7 will cause
irreparable damage to Company and its goodwill, the exact amount of which will be difficult or impossible to ascertain, and that the remedies at law for any such breach will be inadequate. Accordingly, the Executive agrees that in the event of a
breach of any of the covenants contained in Sections 5, 6 and 7, in addition to any other remedy which may be available at law or in equity, the Company will be entitled to specific performance and injunctive relief. 

 

	9.	Assignment and Successors. 

 The Company may assign its rights and obligations under this Agreement to any successor to all or substantially all of the business or the assets of the Company (by merger or otherwise), and may assign or
encumber this Agreement and its rights hereunder as security for indebtedness of the Company and its affiliates. This Agreement shall be binding upon and inure to the benefit of the Company, the Executive and their respective successors, assigns,
personnel and legal representatives, executors, administrators, heirs, distributees, devisees, and legatees, as applicable. None of the Executive’s rights or obligations may be assigned or transferred by the Executive, other than the
Executive’s rights to payments hereunder, which may be transferred only by will or operation of law. Notwithstanding the foregoing, the Executive shall be entitled, to the extent permitted under applicable law and applicable Company
Arrangements, to select and change a beneficiary or beneficiaries to receive compensation hereunder following his death by giving written notice thereof to the Company. 

  
 13 

	10.	Certain Definitions. 

  

	 	(a)	Average Annual Bonus. “Average Annual Bonus” shall mean the average of Executive’s three annual cash bonuses (referred to as the iComp Performance
Bonus) earned in the three fiscal years prior to the fiscal year in which the Date of Termination occurs. 

  

	 	(b)	Cause. The Company shall have “Cause” to terminate the Executive’s employment hereunder upon: 

 

	 	(i)	the Board’s determination that the Executive failed to substantially perform his duties as an employee of the Company (other than any such failure resulting from
the Executive’s Disability) that is reasonably expected to result in, or has resulted in, material economic damage to the Company or any of its affiliates (provided, that, to the extent such failure can be fully cured, the Company shall have
provided the Executive with at least 30 days’ notice of such failure and the Executive has not remedied the failure within the 30-day period); 

  

	 	(ii)	the Board’s determination that the Executive failed in any material respect to carry out or comply with any lawful and reasonable directive of the Board consistent
with the terms of this Agreement (provided, that, to the extent such failure can be fully cured, the Company shall have provided the Executive with at least 30 days’ notice of such failure and the Executive has not remedied the failure within
the 30-day period); 

  

	 	(iii)	the Executive’s conviction, plea of no contest, plea of nolo contendere, or imposition of unadjudicated probation for any felony or crime involving moral
turpitude; 

  

	 	(iv)	the Executive’s unlawful use (including being under the influence) or possession of illegal drugs on the Company’s (or any of its affiliate’s) premises
or while performing the Executive’s duties and responsibilities under this Agreement; or 

  

	 	(v)	the Executive’s commission of an act of fraud, embezzlement, misappropriation, willful misconduct, or breach of fiduciary duty against the Company or any of its
affiliates. 

  

	 	(c)	 Continued Healthcare Coverage. “Continued Healthcare Coverage” shall mean the Company’s reimbursement of Executive for, or direct
payment to the carrier for, the premium costs for the Executive and, where applicable, his spouse and dependents, for a period of time following the Date of Termination (the “Payment Period”), effective with the cessation of coverage as a

  
 14 

	 	
Company employee, under the same or a comparable Company group medical plan to the group medical plan that Executive was participating in as of the Date of Termination; provided that if the same
or comparable Company group medical plan is, at any time during such Payment Period, not available generally to senior officers of the Company, the Executive shall receive reimbursement for, or direct payment to the carrier for, the premium costs
under a group medical plan that is available to such senior officers of the Company; provided, however, if there is no opportunity to be included in a comparable Company group medical plan for all or a portion of the Payment Period, the Executive
may elect coverage under the same provisions as the 2014 Global Expatriate Personnel medical, vision, and dental plan during the remainder of the Payment Period; provided, further, if at any time the Company determines that its payment of any such
premiums on the Executive’s behalf or continued participation in any such plans would result in a violation of applicable law (including but not limited to the 2010 Patient Protection and Affordable Care Act, as amended by the 2010 Health Care
and Education Reconciliation Act), then in lieu of paying premiums pursuant to this clause, the Company shall pay the Executive on the last day of each remaining month of the Payment Period, a fully taxable cash payment equal to the COBRA premium
for such month, subject to applicable tax withholding, such payments to be made without regard to the Executive’s payment of healthcare premiums. 

  

	 	(d)	Date of Termination. “Date of Termination” shall mean (i) if the Executive’s employment is terminated by his death, the date of his death;
(ii) if the Executive’s employment is terminated pursuant to Section 3(a)(ii) – (vi) either the date indicated in the Notice of Termination or the date specified by the Company pursuant to Section 3(b),
whichever is earlier; (iii) if the Executive’s employment is terminated pursuant to Section 3(a)(vii) or Section 3(a)(viii), the expiration of the then-applicable Term. 

 

	 	(e)	Disability. “Disability” shall mean, the Executive’s inability to perform, with or without reasonable accommodation, the essential functions of
his position hereunder for a total of three months during any six-month period as a result of incapacity due to mental or physical illness as determined by a physician selected by the Company or its insurers and acceptable to the Executive or the
Executive’s legal representative, with such agreement as to acceptability not to be unreasonably withheld or delayed. Any refusal by the Executive to submit to a medical examination for the purpose of determining Disability shall be deemed to
constitute conclusive evidence of the Executive’s lack of a Disability. 

  

	 	(f)	 Good Reason. The Executive shall have “Good Reason” to resign his employment within ninety (90) days following (i) a
material diminution in the Executive’s authorities, duties, or responsibilities, (ii) a material change in the geographic location at which the Executive must perform services, which shall not include a relocation of the Executive’s
principal place of 

  
 15 

	 	
employment to any location within a thirty (30) mile radius of the location from which the Executive served the Company immediately prior to the relocation, (iii) a material diminution
in the Executive’s Annual Base Salary from the Annual Base Salary in effect in the prior year, (iv) a material diminution in the Executive’s Target Bonus from the Target Bonus in effect in the prior year, or (v) a material
diminution in the Executive’s LTI Target. The Executive may not resign his employment for Good Reason unless the Executive provided the Company with at least 30 days prior written notice of his intent to resign for Good Reason and the Company
has not cured the breach within 30 days. 

  

	 	(g)	Pro-rated Vesting. “Pro-rated Vesting” shall mean pro-rated vesting of all unvested LTI Program awards granted to the Executive by the Company;
provided, however, that any performance-based LTI Program awards shall only vest and become payable subject to the attainment of the performance measures for the applicable performance period as provided under the terms of the applicable award
agreement, which performance-based amount will vest and be paid to Executive at the time originally scheduled to be paid to Executive under the terms of the applicable award agreement and the amount of vesting, in either case, shall be determined by
multiplying the total amount payable pursuant to the LTI Program award by a fraction, (i) the numerator of which is the number of days from the first day of the applicable LTI Program period through the Date of Termination, and (ii) the
denominator of which is the number of days from the first day of the applicable LTI Program period through the last day of the applicable LTI Program period. 

 

	 	(h)	Specified Entity. “Specified Entity” shall mean any of the following, including their affiliates: (i) ZF Friedrichshafen AG, (ii) Voith AG,
(iii) Eaton Corporation, (iv) Caterpillar, Inc. and (v) ArvinMeritor, Inc. 

  

	11.	Governing Law. 

This Agreement shall be governed, construed, interpreted and enforced in accordance with its express terms, and otherwise in accordance
with the substantive laws of the State of Indiana, without reference to the principles of conflicts of law of the State of Indiana or any other jurisdiction, and where applicable, the laws of the United States. 

 

	12.	Validity. 

 The
invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, which shall remain in full force and effect. 

  
 16 

	13.	Notices. 

 Any
notice, request, claim, demand, document and other communication hereunder to any Party shall be effective upon receipt (or refusal of receipt) and shall be in writing and delivered personally or sent by facsimile or certified or registered mail,
postage prepaid, as follows: 
  

	 	(a)	If to the Company: 

 Allison
Transmission, Inc. 
 Office of the General Counsel 
 One Allison Way 
 Indianapolis, IN 46222 

Facsimile: (317) 242-3254 
  

	 	(b)	If to the Executive: 

 Lawrence
E. Dewey 
 and copies to: 
 Krieg DeVault LLP 
 One Indiana Square, Suite 2800 

Indianapolis, IN 46204-2079 
 Attention: Sharon B. Hearn 
 Facsimile: (317) 636-1507 

or at any other address as any Party shall have specified by notice in writing to the other Party. 

 

	14.	Counterparts. 

This Agreement may be executed in several counterparts, each of which shall be deemed to be an original, but all of which together will
constitute one and the same Agreement. Signatures delivered by facsimile shall be deemed effective for all purposes. 
  

	15.	Entire Agreement. 

The terms of this Agreement are intended by the Parties to be the final expression of their agreement with respect to the employment of
the Executive by the Company and supersede all prior understandings and agreements, whether written or oral, including the Employment Agreement between the Company and the Executive dated February 7, 2008, as amended. The Parties further intend
that this Agreement shall constitute the complete and exclusive statement of their terms and that no extrinsic evidence whatsoever may be introduced in any judicial, administrative, or other legal proceeding to vary the terms of this Agreement.

  
 17 

	16.	Amendments; Waivers. 

 This Agreement may not be modified, amended, or terminated except by an instrument in writing, signed by the Executive and a duly authorized officer of Company. By an instrument in writing similarly
executed, the Executive or a duly authorized officer of the Company may waive compliance by the other Party or Parties with any specifically identified provision of this Agreement that such other Party was or is obligated to comply with or perform;
provided, however, that such waiver shall not operate as a waiver of, or estoppel with respect to, any other or subsequent failure. No failure to exercise and no delay in exercising any right, remedy, or power hereunder preclude any other or further
exercise of any other right, remedy, or power provided herein or by law or in equity. Except as otherwise set forth in this Agreement, the respective rights and obligations of the Parties under this Agreement shall survive any termination of the
Executive’s employment. 
  

	17.	No Inconsistent Actions. 

 The Parties hereto shall not voluntarily undertake or fail to undertake any action or course of action inconsistent with the provisions or essential intent of this Agreement. Furthermore, it is the intent
of the Parties hereto to act in a fair and reasonable manner with respect to the interpretation and application of the provisions of this Agreement. 
  

	18.	Construction. 

This Agreement shall be deemed drafted equally by both the Parties. Its language shall be construed as a whole and according to its fair
meaning. Any presumption or principle that the language is to be construed against any Party shall not apply. The headings in this Agreement are only for convenience and are not intended to affect construction or interpretation. Any references to
paragraphs, subparagraphs, sections or subsections are to those parts of this Agreement, unless the context clearly indicates to the contrary. Also, unless the context clearly indicates to the contrary, (a) the plural includes the singular and
the singular includes the plural; (b) “and” and “or” are each used both conjunctively and disjunctively; (c) “any,” “all,” “each,” or “every” means “any and all,” and
“each and every”; (d) “includes” and “including” are each “without limitation”; (e) “herein,” “hereof,” “hereunder” and other similar compounds of the word
“here” refer to the entire Agreement and not to any particular paragraph, subparagraph, section or subsection; and (f) all pronouns and any variations thereof shall be deemed to refer to the masculine, feminine, neuter, singular or
plural as the identity of the entities or persons referred to may require. 
  

	19.	Arbitration. 

 Any
controversy, claim or dispute arising out of or relating to this Agreement, shall be settled solely and exclusively by binding arbitration in Indianapolis, Indiana. Such arbitration shall be conducted in accordance with the then prevailing JAMS
Streamlined Arbitration Rules & Procedures, with the following exceptions if in conflict: (a) one arbitrator shall be chosen by JAMS; (b) each Party to the arbitration will pay its pro rata share of the expenses and fees of the
arbitrator, together with other expenses of the arbitration incurred or approved by the arbitrator; and (c) arbitration may proceed in the absence of any Party if written notice (pursuant to the

  
 18 

 
JAMS’ rules and regulations) of the proceedings has been given to such Party. Each Party shall bear its own attorneys fees and expenses. The Parties agree to abide by all decisions and
awards rendered in such proceedings. Such decisions and awards rendered by the arbitrator shall be final and conclusive. All such controversies, claims or disputes shall be settled in this manner in lieu of any action at law or equity; provided,
however, that nothing in this subsection shall be construed as precluding the bringing an action for injunctive relief as provided in Section 8. 
  

	20.	Enforcement. 

 If
any provision of this Agreement is held to be illegal, invalid or unenforceable under present or future laws effective during the term of this Agreement, such provision shall be fully severable; this Agreement shall be construed and enforced as if
such illegal, invalid or unenforceable provision had never comprised a portion of this Agreement; and the remaining provisions of this Agreement shall remain in full force and effect and shall not be affected by the illegal, invalid or unenforceable
provision or by its severance from this Agreement. Furthermore, in lieu of such illegal, invalid or unenforceable provision there shall be added automatically as part of this Agreement a provision as similar in terms to such illegal, invalid or
unenforceable provision as may be possible and be legal, valid and enforceable. 
  

	21.	Withholding. 

 The
Company shall be entitled to withhold from any amounts payable under this Agreement any federal, state, local or foreign withholding or other taxes or charges which the Company is required to withhold. The Company shall be entitled to rely on an
opinion of counsel if any questions as to the amount or requirement of withholding shall arise. 
  

	22.	Employee Acknowledgement. 

 The Executive acknowledges that he has read and understands this Agreement, is fully aware of its legal effect, has not acted in reliance upon any representations or promises made by the Company other
than those contained in writing herein, and has entered into this Agreement freely based on his own judgment. 
  

	23.	Section 409A. 

  

	 	(a)	General. The intent of the Parties is that the payments and benefits under this Agreement comply with or be exempt from Section 409A of the Internal Revenue
Code of 1986 (the “Code”), as amended, and the regulations and guidance promulgated thereunder (collectively, “Section 409A”) and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to
be in compliance therewith. 

  

	 	(b)	 Separation from Service. Notwithstanding anything in this Agreement to the contrary, any compensation or benefits payable under this Agreement
that is considered nonqualified deferred compensation under Section 409A and is designated under this Agreement as payable upon Executive’s termination of employment shall be payable only upon Executive’s “separation from
service” with the Company within the meaning of Section 409A (a “Separation from  

  
 19 

	 	
Service”) and, except as provided below, any such compensation or benefits described in Section 4 shall not be paid, or, in the case of installments, shall not commence payment,
until the thirtieth (60th) day following Executive’s Separation from Service (the “First Payment Date”). Any installment payments that would have been made to Executive during the sixtieth (60th) day period immediately following Executive’s Separation
from Service but for the preceding sentence shall be paid to Executive on the First Payment Date and the remaining payments shall be made as provided in this Agreement. 

 

	 	(c)	Specified Employee. Notwithstanding anything in this Agreement to the contrary, if Executive is deemed by the Company at the time of Executive’s Separation
from Service to be a “specified employee” for purposes of Section 409A, to the extent delayed commencement of any portion of the benefits to which Executive is entitled under this Agreement is required in order to avoid a prohibited
distribution under Section 409A, such portion of Executive’s benefits shall not be provided to Executive prior to the earlier of (i) the expiration of the six-month period measured from the date of Executive’s Separation from
Service with the Company or (ii) the date of Executive’s death. Upon the first business day following the expiration of the applicable Section 409A period, all payments deferred pursuant to the preceding sentence shall be paid in a
lump sum to Executive (or Executive’s estate or beneficiaries), and any remaining payments due to Executive under this Agreement shall be paid as otherwise provided herein. 

 

	 	(d)	Expense Reimbursements. To the extent that any reimbursements under this Agreement are subject to Section 409A, any such reimbursements payable to Executive
shall be paid to Executive no later than December 31 of the year following the year in which the expense was incurred; provided, that Executive submits Executive’s reimbursement request promptly following the date the expense is incurred,
the amount of expenses reimbursed in one year shall not affect the amount eligible for reimbursement in any subsequent year, other than medical expenses referred to in Section 105(b) of the Code, and Executive’s right to reimbursement
under this Agreement will not be subject to liquidation or exchange for another benefit. 

  

	 	(e)	Installments. Executive’s right to receive any installment payments under this Agreement, including without limitation any continuation salary payments that
are payable on Company payroll dates, shall be treated as a right to receive a series of separate payments and, accordingly, each such installment payment shall at all times be considered a separate and distinct payment as permitted under
Section 409A. Except as otherwise permitted under Section 409A, no payment hereunder shall be accelerated or deferred unless such acceleration or deferral would not result in additional tax or interest pursuant to Section 409A

  
 20 

	24.	Indemnification. 

The Company shall indemnify the Executive to the maximum extent permitted under the General Corporation Law of the State of Delaware for
acts taken within the scope of his employment. To the extent that the Company obtains coverage under a director and officer indemnification policy, the Executive will be entitled to such coverage on a basis that is no less favorable than the
coverage provided to any other officer or director of the Company. 
 [remainder of page intentionally left blank] 

  
 21 

 IN WITNESS WHEREOF, the Parties have executed this Agreement on the date and year first
above written. 
  

			
	COMPANY
		
	By:	 	 /s/ Eric C. Scroggins

		 	Name: Eric C. Scroggins
		 	Title: Vice President, General Counsel and Secretary
	
	EXECUTIVE
		
	By:	 	 /s/ Lawrence E. Dewey

		 	Lawrence E. Dewey

 Exhibit A 

General Release and Waiver* 
 For and in consideration of the payments and other benefits due to Lawrence E. Dewey (the “Executive”) pursuant to the Employment Agreement, dated as of February xx, 2014, by and between
Allison Transmission, Inc. (the “Company”) and the Executive (the “Employment Agreement”), and for other good and valuable consideration, the Executive hereby agrees, for the Executive, the Executive’s spouse
and child or children (if any), the Executive’s heirs, beneficiaries, devisees, executors, administrators, attorneys, insurers, personal representatives, successors and assigns, to forever release, discharge and covenant not to sue (the
“Release”) the Company, or any of its divisions, affiliates, subsidiaries, parents, branches, predecessors, successors, assigns, and, with respect to such entities, their officers, directors, trustees, employees, agents,
shareholders, administrators, general or limited partners, representatives, attorneys and fiduciaries, past, present and future (the “Released Parties”) from any and all claims of any kind arising out of, or related to, his
employment with the Company, its affiliates and subsidiaries (collectively, with the Company, the “Affiliated Entities”), the Executive’s separation from employment with the Affiliated Entities, which the Executive now has or
may have against the Released Parties, whether known or unknown to the Executive, by reason of facts which have occurred on or prior to the date that the Executive has signed this Release. Such released claims include, without limitation, any and
all claims relating to the foregoing under federal, state or local laws pertaining to employment, including, without limitation, the Age Discrimination in Employment Act, Title VII of the Civil Rights Act of 1964, as amended, 42 U.S.C.
Section 2000e et. seq., the Fair Labor Standards Act, as amended, 29 U.S.C. Section 201 et. seq., the Americans with Disabilities Act, as amended, 42 U.S.C. Section 12101 et. seq. the
Reconstruction Era Civil Rights Act, as amended, 42 U.S.C. Section 1981 et. seq., the Rehabilitation Act of 1973, as amended, 29 U.S.C. Section 701 et. seq., the Family and Medical Leave Act of 1992, 29 U.S.C.
Section 2601 et. seq., and any and all state or local laws regarding employment discrimination and/or federal, state or local laws of any type or description regarding employment, including but not limited to any claims arising
from or derivative of the Executive’s employment with the Affiliated Entities, as well as any and all such claims under state contract or tort law. 
 The Executive has read this Release carefully, acknowledges that the Executive has been given at least twenty-one (21) days to consider all of its terms and has been advised to consult with an
attorney and any other advisors of the Executive’s choice prior to executing this Release, and the Executive fully understands that by signing below the Executive is voluntarily giving up any right which the Executive may have to sue or bring
any other claims against the Released Parties, including any rights and claims under the Age Discrimination in Employment Act. The Executive also understands that the Executive has a period of seven (7) days after signing this Release within
which to revoke his agreement, and that neither the Company nor any other person is obligated to make any payments or provide any other benefits to the Executive pursuant to the Employment Agreement until eight (8) days have passed since the
Executive’s 
  

	*	The Company may adjust the terms of this form release from time to time, including, without limitation, to reflect any changes in applicable laws.

  
 23 

 
signing of this Release without the Executive’s signature having been revoked other than any accrued obligations or other benefits payable pursuant to the terms of the Company’s normal
payroll practices or employee benefit plans. Finally, the Executive has not been forced or pressured in any manner whatsoever to sign this Release, and the Executive agrees to all of its terms voluntarily. 

Notwithstanding anything else herein to the contrary, this Release shall not affect: (i) the Company’s obligations under any
compensation or employee benefit plan, program or arrangement (including, without limitation, obligations to the Executive under any stock option, stock award or agreements or obligations under any pension, deferred compensation or retention plan)
provided by the Affiliated Entities where the Executive’s compensation or benefits are intended to continue or the Executive is to be provided with compensation or benefits, in accordance with the express written terms of such plan, program or
arrangement, beyond the date of the Executive’s termination; or (ii) rights to indemnification or liability insurance coverage the Executive may have under the by-laws of the Company or applicable law. 

This Release is subject to Sections 11 and 19 of the Employment Agreement. This Release is final and binding and may not be
changed or modified except in a writing signed by both parties. 
  

					
	  
	 		 	  

	Date	 		 	Lawrence E. Dewey
			
	  
	 		 	  

	Date	 		 	Allison Transmission, Inc.

  
 24

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00229-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00229-of-00352.parquet"}]]